BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6167816)

  • 1. Effects of nitroglycerin ointment on plasma norepinephrine and cyclic nucleotides in congestive heart failure.
    Ogasawara B; Ogawa K; Sassa H
    J Cardiovasc Pharmacol; 1981; 3(4):867-75. PubMed ID: 6167816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma renin activity and plasma concentrations of norepinephrine and cyclic nucleotides in heart failure after prazosin.
    Ogasawara B; Ogawa K; Hayashi H; Sassa H
    Clin Pharmacol Ther; 1981 Apr; 29(4):464-71. PubMed ID: 6258839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive effects of angiotensin-converting enzyme inhibitors on nitrate tolerance during continuous transdermal application of nitroglycerin in patients with chronic heart failure.
    Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
    Jpn Circ J; 1998 May; 62(5):353-8. PubMed ID: 9626903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of hemodynamic effects and plasma cyclic guanosine monophosphate of nicorandil and nitroglycerin in patients with congestive heart failure.
    Tsutamoto T; Kinoshita M; Hisanaga T; Maeda Y; Maeda K; Wada A; Fukai D; Yoshida S
    Am J Cardiol; 1995 Jun; 75(16):1162-5. PubMed ID: 7762505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiologic and prognostic considerations in circulatory insufficiency in congestive heart failure: receptor function.
    Ogawa K; Ito T
    Jpn Circ J; 1989 Feb; 53(2):123-30. PubMed ID: 2541267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure.
    Elkayam U; Roth A; Henriquez B; Weber L; Tonnemacher D; Rahimtoola SH
    Am J Cardiol; 1985 Sep; 56(8):555-9. PubMed ID: 3929585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased plasma cyclic nucleotide concentrations in congestive heart failure.
    Ogawa K; Shiozu H; Mizuno K; Ban M; Ito T; Satake T
    Br Heart J; 1984 Nov; 52(5):524-9. PubMed ID: 6093837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic and hormonal response to transdermal nitroglycerin in normal subjects and in patients with congestive heart failure.
    Olivari MT; Carlyle PF; Levine TB; Cohn JN
    J Am Coll Cardiol; 1983 Nov; 2(5):872-8. PubMed ID: 6415142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of endothelium-dependent vasodilation by low-dose nitroglycerin in patients with congestive heart failure.
    Schwarz M; Katz SD; Demopoulos L; Hirsch H; Yuen JL; Jondeau G; LeJemtel TH
    Circulation; 1994 Apr; 89(4):1609-14. PubMed ID: 8149528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure. Differential effects of nitroprusside, phentolamine, and nitroglycerin on cardiac function and peripheral circulation.
    Miller RR; Vismara LA; Williams DO; Amsterdam EA; Mason DT
    Circ Res; 1976 Jul; 39(1):127-33. PubMed ID: 819179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurohumoral and hemodynamic effects of lower body negative pressure in patients with congestive heart failure.
    Mohanty PK; Arrowood JA; Ellenbogen KA; Thames MD
    Am Heart J; 1989 Jul; 118(1):78-85. PubMed ID: 2662730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure.
    Elkayam U; Kulick D; McIntosh N; Roth A; Hsueh W; Rahimtoola SH
    Circulation; 1987 Sep; 76(3):577-84. PubMed ID: 3113764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of nitroglycerin ointment in congestive heart failure.
    Taylor WR; Forrester JS; Magnusson P; Takano T; Chatterjee K; Swan HJ
    Am J Cardiol; 1976 Oct; 38(4):469-73. PubMed ID: 823808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure.
    Moe GW; Canepa-Anson R; Armstrong PW
    J Cardiovasc Pharmacol; 1992 May; 19(5):691-700. PubMed ID: 1381766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of normal neurohormonal activity in mild congestive heart failure and stimulating effect of upright posture and diuretics.
    Kubo SH; Clark M; Laragh JH; Borer JS; Cody RJ
    Am J Cardiol; 1987 Dec; 60(16):1322-8. PubMed ID: 3318370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative hemodynamic effects of chewable isosorbide dinitrate and nitroglycerin in patients with congestive heart failure.
    Mikulic E; Franciosa JA; Cohn JN
    Circulation; 1975 Sep; 52(3):477-82. PubMed ID: 808359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intravenous nitroglycerin on hemodynamics in infants and children with congestive heart failure.
    Zeng H; Sun L; Li W; Du J
    Chin Med J (Engl); 2000 Apr; 113(4):328-31. PubMed ID: 11775229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged hemodynamic effect of a slow-release nitroglycerin ointment.
    Klein HO; Ninio R; Blank I; di Segni E; Beker B; Oren V; Kaplinsky E
    Am J Cardiol; 1986 Sep; 58(6):436-42. PubMed ID: 3019118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid development of nitrate tolerance in healthy volunteers: assessment using spectral analysis of short-term blood pressure and heart rate variability.
    Cloarec-Blanchard L; Funck-Brentano C; Carayon A; Jaillon P
    J Cardiovasc Pharmacol; 1994 Aug; 24(2):266-73. PubMed ID: 7526059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic, renal, and hormonal effects of 8-Br-cyclic GMP in conscious dogs with and without congestive heart failure.
    Elsner D; Kromer EP; Riegger GA
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):241-7. PubMed ID: 2476597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.